首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   600890篇
  免费   40026篇
  国内免费   11430篇
耳鼻咽喉   7531篇
儿科学   12373篇
妇产科学   15907篇
基础医学   82825篇
口腔科学   16808篇
临床医学   54086篇
内科学   116150篇
皮肤病学   11922篇
神经病学   40719篇
特种医学   21490篇
外国民族医学   155篇
外科学   87361篇
综合类   31485篇
现状与发展   25篇
一般理论   103篇
预防医学   32726篇
眼科学   15363篇
药学   51851篇
  116篇
中国医学   8638篇
肿瘤学   44712篇
  2022年   6166篇
  2021年   9220篇
  2020年   6278篇
  2019年   7537篇
  2018年   9728篇
  2017年   7874篇
  2016年   7720篇
  2015年   10178篇
  2014年   13446篇
  2013年   15251篇
  2012年   21547篇
  2011年   22884篇
  2010年   13843篇
  2009年   12103篇
  2008年   18598篇
  2007年   19653篇
  2006年   19589篇
  2005年   18358篇
  2004年   15751篇
  2003年   15066篇
  2002年   13985篇
  2001年   36051篇
  2000年   37026篇
  1999年   31201篇
  1998年   8606篇
  1997年   7362篇
  1996年   6149篇
  1995年   5632篇
  1994年   5016篇
  1993年   4304篇
  1992年   20142篇
  1991年   18870篇
  1990年   17941篇
  1989年   17575篇
  1988年   15975篇
  1987年   15251篇
  1986年   14072篇
  1985年   13163篇
  1984年   8876篇
  1983年   7286篇
  1982年   3664篇
  1979年   7369篇
  1978年   4545篇
  1977年   3959篇
  1975年   3845篇
  1974年   4442篇
  1973年   4274篇
  1972年   4150篇
  1971年   3999篇
  1969年   3662篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
3.

Background

Rosacea is a chronic inflammatory skin condition whose etiology has been linked to mast cells and the antimicrobial peptide cathelicidin LL-37. Individuals with refractory disease have demonstrated clinical benefit with periodic injections of onabotulinum toxin, but the mechanism of action is unknown.

Objectives

To investigate the molecular mechanism by which botulinum toxin improves rosacea lesions.

Methods

Primary human and murine mast cells were pretreated with onabotulinum toxin A or B or control. Mast cell degranulation was evaluated by β-hexosaminidase activity. Expression of botulinum toxin receptor Sv2 was measured by qPCR. The presence of SNAP-25 and VAMP2 was established by immunofluorescence. In vivo rosacea model was established by intradermally injecting LL-37 with or without onabotulinum toxin A pretreatment. Mast cell degranulation was assessed in vivo by histologic counts. Rosacea biomarkers were analyzed by qPCR of mouse skin sections.

Results

Onabotulinum toxin A and B inhibited compound 48/80-induced degranulation of both human and murine mast cells. Expression of Sv2 was established in mouse mast cells. Onabotulinum toxin A and B increased cleaved SNAP-25 and decreased VAMP2 staining in mast cells respectively. In mice, injection of onabotulinum toxin A significantly reduced LL-37-induced skin erythema, mast cell degranulation, and mRNA expression of rosacea biomarkers.

Conclusions

These findings suggest that onabotulinum toxin reduces rosacea-associated skin inflammation by directly inhibiting mast cell degranulation. Periodic applications of onabotulinum toxin may be an effective therapy for refractory rosacea and deserves further study.  相似文献   
4.
5.
Abstract

This study was undertaken to compare the concentrations of pro- and anti-angiogenic growth factors, nitric oxide (NO) stable metabolites in maternal serum and embryonic left ventricular (LV) isovolumic relaxation time (IRT, ms) during the first trimester in two groups of women: with pregnancy conceived by assisted reproductive technologies (ART, n?=?39) and normally conceived (control group, n?=?68) pregnancy. The concentration of vasoconstrictor endothelin 1 was 45.5 times more in ART than in control group. On the contrary, the concentrations of NO stable metabolites in ART were 1.9 times less than in control women. The assessment of angiogenic suppressors in ART women demonstrates the decrease in s-endoglin concentration was 1.6 times and in soluble receptor to vascular endothelial growth factor concentration was 2.0 times in comparison with control group. There was a significant increase in LV IRT in ART embryos in comparison to control ones. These data suggest significant changes in pro- anti-angiogenic factors balance and increase in vascular impedance in ART-conceived embryos.  相似文献   
6.
Abstract

Purpose: We examined underlying psychosocial processes of a behavioral treatment for urinary incontinence (UI) of prostate cancer survivors.

Design: Secondary analysis of data collected from a clinical trial.

Sample: Two hundred forty-four prostate cancer survivors who participated in a clinical trial of behavioral intervention to UI as intervention or control subjects.

Methods: The participants had a 3-month behavioral intervention or usual care and were followed up for an additional 3?months. They were assessed at baseline, 3, and 6?months. Latent growth curve models were performed to examine trajectories of each study variable and relationships among the variables.

Findings: Increasing self-efficacy and social support were significantly and independently associated with more reduction of urinary leakage frequency over time.

Implications for psychosocial oncology: Providing problem-solving skills and social support, including peer support, are essential for empowering patients to reduce UI.  相似文献   
7.
Conclusion  Several quality-control measures take place before (patient and camera preparation) and during SPECT acquisition to achieve high-quality images. Not uncommonly, technologists and physicians are left with suboptimal images that have to be addressed to reach the “right answer” for patient diagnosis and hence management. In many cases patients may be reimaged, especially if the problem is detected early, but in other cases either the patient has left the nuclear laboratory or there is an inevitable problem that, even with reimaging, will not be resolved. In these situations the technologist and physician have to seek the available techniques to obtain the best images possible. These resources are discussed in this issue as an aid in quality control to obtain the best possible images.  相似文献   
8.
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号